This web site was copied prior to January 20, 2005. It is now a Federal record managed by the National Archives and Records Administration. External links, forms, and search boxes may not function within this collection. Learn more.   [hide]
ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Status : ALL_STUDIES


11969 studies were found. Here are studies 1 to 50.
1.No longer recruiting"Clinical Trials to Enhance Elders' Oral Health" ("TEETH")
Conditions: Tooth Loss; Periodontal Disease; Tooth decay
2.CompletedA "Pre-Enrollment" Protocol for HIV-Infected Adolescents
Condition: HIV Infections
3.RecruitingThe "Reach For Health" Program: Delaying Sexual Activity in Children
Conditions: Sex Behavior; Child Behavior
4.Recruiting"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
Condition: Prostate Cancer
5.No longer recruiting(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who Receive Neurotoxic Therapy
Conditions: Cancer; Central Nervous System Disease; Nervous System Disease; Peripheral Nervous System Disease; Progressive Multifocal Leukoencephalopathy
6.Completed(PET) Imaging in the Management of Patients with Solitary Pulmonary Nodules
Condition: Benign and malignant solitary pulmonary nodules
7.Completed(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC
Condition: HIV Infections
8.Completed1-Octanol to Treat Essential Tremor
Condition: Essential Tremor
9.Completed1-Octanol to Treat Essential Tremor
Condition: Essential Tremor
10.No longer recruitingA 1-Year Study of an Investigational Drug in Obese Patients
Condition: Obesity
11.Suspended10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
Conditions: adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma
12.No longer recruiting10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; Quality of Life
13.Completed10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
14.No longer recruiting12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.
Condition: Hepatitis C
15.Completed12 week,comparing safety of HMR1964 & insulin aspart used in continuous subcutaneous infusion in type 1 diabetes.
Condition: Diabetes, type I
16.Recruiting12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
Conditions: chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
17.No longer recruitingA 12-week, multicenter, safety and dose-ranging study of 3 oral doses of TCH346 in patients with Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
18.Recruiting131MIBG to Treat Malignant Pheochromocytoma
Condition: Pheochromocytoma
19.RecruitingA 14-day study of Racivir when used in combination in HIV-Infected Males
Condition: HIV Infections
20.Recruiting17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer
21.Recruiting17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Cancer
22.Recruiting17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas
Conditions: adult solid tumor; Leukemia; Lymphoma
23.Recruiting17-DMAG to Treat Patients with Solid Tumors or Lymphomas
Conditions: Neoplasms; Lymphoma
24.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor
Condition: unspecified adult solid tumor, protocol specific
25.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
Condition: Cancer
26.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma
27.Not yet recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
28.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
Conditions: adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma; ...
29.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Stage III or Stage IV Melanoma
Conditions: stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
30.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Von Hippel-Lindau Disease and Kidney Cancer
Conditions: stage I renal cell cancer; von Hippel-Lindau Syndrome
31.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Neuroblastoma; Osteosarcoma
32.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Conditions: unspecified childhood solid tumor, protocol specific; recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; ...
33.Recruiting17AAG to Treat Kidney Tumors in von Hippel-Lindau Disease
Conditions: Hippel-Lindau Disease; Kidney Cancer
34.Recruiting2 doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
35.Recruiting2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
36.No longer recruiting2-Methoxyestradiol (2-ME2) to Treat Solid Tumor Cancers
Conditions: Pathologic Angiogenesis; Neoplasm
37.Recruiting2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
Conditions: refractory plasma cell neoplasm; stage III multiple myeloma; unspecified adult solid tumor, protocol specific
38.No longer recruitingA 2-Year Study of an Investigational Drug in Obese Patients
Condition: Obesity
39.RecruitingA 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH).
Condition: Prostatic Hyperplasia
40.RecruitingA 24 Week Study of Daily Oral Investigational Drug vs Placebo in Patients with Asthma
Condition: Asthma
41.CompletedA 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients with AIDS
Conditions: Cryptosporidiosis; HIV Infections
42.No longer recruiting3 Different Dose Levels of CCI-779 in Subjects with Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy
Condition: Rheumatoid Arthritis
43.Recruiting3 Fixed Dosages of Extended Release OROS Paliperidone and Olanzapine in the Treatment of Subjects with Schizophrenia
Condition: Schizophrenia
44.No longer recruiting3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
45.Not yet recruiting3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
46.No longer recruiting3-AP and Cytarabine in Treating Patients With Hematologic Cancer
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; myelodysplastic and myeloproliferative disease
47.Recruiting3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
48.Recruiting3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer
49.Recruiting3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer
Condition: Non-small cell lung cancer
50.Recruiting3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act